BRIACELL THERAPEUTICS CORP. (BCTX) Operating cash flow 2021–2026
BRIACELL THERAPEUTICS CORP. (BCTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.7MFY2026 · since FY2021: -$7.8M → -$28.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$28.7M | -1.7% |
| FY2025 | -$28.2M | -16.8% |
| FY2024 | -$24.1M | -1.6% |
| FY2023 | -$23.7M | -90.2% |
| FY2022 | -$12.5M | -61.1% |
| FY2021 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTX financial trends
BCTX RevenueBCTX Net incomeBCTX Net marginBCTX Gross profitBCTX Gross marginBCTX Operating incomeBCTX Operating marginBCTX Free cash flowBCTX Capital expendituresBCTX Return on equityBCTX Stock buybacksBCTX Dividends paidBCTX Total assetsBCTX Total liabilitiesBCTX Shareholders’ equityBCTX overview →